This topic contains a solution. Click here to go to the answer

Author Question: To restrict a firm's monopoly power, why can't antitrust authorities just set a floor or a ceiling ... (Read 112 times)

Medesa

  • Hero Member
  • *****
  • Posts: 507
To restrict a firm's monopoly power, why can't antitrust authorities just set a floor or a ceiling in the market?
 
  What will be an ideal response?

Question 2

What is meant by utility?
 
  What will be an ideal response?



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

InfiniteSteez

  • Sr. Member
  • ****
  • Posts: 340
Answer to Question 1

It is difficult to set a fair price in a monopolized market. Antitrust authorities can either set a price in the market that is equal to marginal cost or can require firms to set a price that is equal to average cost. The price set at marginal cost is called the efficient price or the socially-optimal price. While this is the price at which social surplus is maximized, in a natural monopoly, marginal cost is lower than average total cost at every quantity. So, at this price, the firm will experience an economic loss and will eventually exit the industry. Alternatively, the government could require firms to set the price at average total cost. This would allow the monopolist to stay in business as the firm would not incur losses. However, both these forms of price regulation would mean that the firm has no incentive to minimize costs or to innovate and produce new goods and services.

Answer to Question 2

Utility is the satisfaction (or reward) a product yields relative to its alternatives. It is the basis of choice.




Medesa

  • Member
  • Posts: 507
Reply 2 on: Jun 29, 2018
Wow, this really help


Zebsrer

  • Member
  • Posts: 284
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

Did you know?

Persons who overdose with cardiac glycosides have a better chance of overall survival if they can survive the first 24 hours after the overdose.

Did you know?

The first documented use of surgical anesthesia in the United States was in Connecticut in 1844.

Did you know?

The horizontal fraction bar was introduced by the Arabs.

For a complete list of videos, visit our video library